Table 1.
Sample information: (A) T1D sample characteristics including age, gender and known T1D autoantibodies (AAb) status; (B) JIA sample characteristics including age, gender, number of joints affected and antinuclear antibodies (ANA) status (GADA, IA-2A and ZnT8A).
| (A) | |||
|---|---|---|---|
| Characteristics | New-Onset Patients (n=20) | Healthy Controls (n=20) | |
| Age | Mean±SD | 13.2±4.96 | 13.3±4.94 |
| Median | 13.5 | 13.5 | |
| Gender | Male(%) | (14)70% | (14)70% |
| AAb Status | GADA positive | (14)70% | 0 |
| IA-2A positive | (14)70% | 0 | |
| ZnT8A positive | (11)55% | 0 | |
| (B) | ||||
|---|---|---|---|---|
| Characteristics | JIA (n=10) | JIA with Uveitis (n=10) | Healthy controls (n=10) | |
| Age | Mean± SD | 5.83±3.86 | 4.78±3.43 | 6.17±6.46 |
| Median | 3.86 | 3.51 | 2.71 | |
| Gender | Male(%) | (1)10% | (1)10% | (1)10% |
| Disease Subtype | Oligo | 7 | 7 | NA |
| Ext.Oligo | 1 | 1 | NA | |
| Poly | 2 | 2 | NA | |
| ANA status | Negative | (5)50% | (5)50% | NA |